Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
365.10    -2.30 (-0.63%)
Bid:
366.50
Ask:
366.80
Spread: 0.30 (0.082%)
Market Cap: £7.50b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Director/PDMR Shareholding - Replacement

20 Nov 2014 17:21

RNS Number : 6237X
Marks & Spencer Group PLC
20 November 2014
 



REPLACEMENT ANNOUNCEMENT TO RNS NUMBER 5025W RELEASED ON 7 NOVEMBER 2014 AT 15:32.

The announcement released on 7 November 2014 at 15:32 under the RNS number 5025W contained a typographical error relating to the resultant total shareholding following the transaction for both individuals. The announcement below is a replacement of the earlier disclosure.

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

Please complete all relevant boxes in block capital letters.

 

1. Name of the issuer

MARKS AND SPENCER GROUP PLC

2. State whether the notification relates to

(i) a transaction notified in accordance with DR 3.1.4R(1)(a); or

(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 793 of the Companies Act 2006; or

(iii) both (i) and (ii)

DISCLOSURE RELATES TO POINT (i)

3. Name of person discharging managerial responsibilities/director

MARC BOLLAND & LAURA WADE-GERY

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

DISCLOSURE RELATES TO POINT 3

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

ORDINARY 25p SHARES

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

MARC BOLLAND:

DEFERRED SHARE BONUS PLAN SHARES AND PERFORMANCE SHARE PLAN AWARD TRANSFERRED INTO THE NAME OF MARC BOLLAND

LAURA WADE-GERY:

RESTRICTED SHARE PLAN AWARD SHARES AND PERFORMANCE SHARE PLAN AWARD TRANSFERRED INTO THE NAME OF LAURA WADE-GERY

(SEE NUMBER 9 BELOW FOR NUMBER OF SHARES)

8 State the nature of the transaction

MARC BOLLAND:

EXERCISE OF 162,263 OPTIONS (WHICH VESTED ON 9 JUNE 2014) FROM THE 2011 DEFERRED SHARE BONUS PLAN (DSBP) AWARD, AND SUBSEQUENT SALE TO COVER TAX AND NI LIABILITY.

EXERCISE OF 52,227 OPTIONS (WHICH VESTED ON 9 JUNE 2014) FROM THE 2011 PERFORMANCE SHARE PLAN (PSP) AWARD, AND SUBSEQUENT SALE TO COVER TAX AND NI LIABILITY

LAURA WADE-GERY:

EXERCISE OF 33,746 OPTIONS (WHICH VESTED ON 25 JULY 2013) FROM THE 2011 PERFORMANCE SHARE PLAN (PSP) AWARD, AND SUBSEQUENT SALE TO COVER TAX AND NI LIABILITY

EXERCISE OF 126,225 AND 77,677 RESTRICTED SHARE PLAN (RSP) AWARDS (WHICH VESTED ON 25 JULY 2013 AND 25 JULY 2014 RESPECTIVELY), AND SUBSEQUENT SALE TO COVER TAX AND NI LIABILITY

9. Number of shares, debentures or financial instruments relating to shares acquired

NAME

AWARD TYPE

NO. OF OPTIONS EXERCISED

NUMBER OF SHARES SOLD

PRICE

TOTAL SHAREHOLDING FOLLOWING TRANSACTION

MARC BOLLAND

DSBP

162,263

76,532

469.8p

611,436

PSP

52,227

24,633

469.8p

LAURA WADE-GERY

PSP

33,746

15,917

471.0p

243,817

RSP

203,902

96,238

471.0p

 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

DE MINIMIS

11. Number of shares, debentures or financial instruments relating to shares disposed

SEE 9 ABOVE

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 

N/A

13. Price per share or value of transaction

SEE 9 ABOVE

14. Date and place of transaction

MARC BOLLAND: 7 NOVEMBER 2014, LONDON

LAURA WADE-GERY: 6 NOVEMBER 2014, LONDON

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

SEE 9 ABOVE

16. Date issuer informed of transaction

7 NOVEMBER 2014

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

 

17 Date of grant

 

………………………………

 

18. Period during which or date on which it can be exercised

 

………………………………

 

19. Total amount paid (if any) for grant of the option

 

………………………………

 

20. Description of shares or debentures involved (class and number)

 

………………………………

………………………………

 

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

 

………………………………

 

22. Total number of shares or debentures over which options held following notification

 

………………………………

 

23. Any additional information

 

24. Name of contact and telephone number for queries

ADAEZE OKIKE

020 8718 4030

Name and signature of duly authorised officer of issuer responsible for making notification

ADAEZE OKIKE

Date of notification

20 NOVEMBER 2014

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAXFEAAFLFFF
Date   Source Headline
1st Jun 202610:00 amRNSAnnual Financial Report
1st Jun 20269:00 amRNSIssue of Shares and Total Voting Rights
28th May 20264:23 pmRNSLichfield Fulfilment Centre Disposal Completion
28th May 20262:12 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
20th May 202610:30 amRNSDirectorate change
20th May 20267:00 amRNSFinal Results
1st May 20269:00 amRNSIssue of Shares and Total Voting Rights
28th Apr 20262:57 pmRNSDirector/PDMR Shareholding
28th Apr 202610:40 amRNSHolding(s) in Company
1st Apr 20269:00 amRNSIssue of Shares and Total Voting Rights
30th Mar 20262:07 pmRNSDirector/PDMR Shareholding
24th Mar 202610:35 amRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20261:00 pmRNSIssue of Shares and Total Voting Rights
19th Feb 20269:38 amRNSHolding(s) in Company
17th Feb 20263:23 pmRNSDirector/PDMR Shareholding
5th Feb 202611:48 amRNSDirector Declaration
3rd Feb 20269:57 amRNSDirector/PDMR Shareholding
2nd Feb 20269:00 amRNSTotal Voting Rights
29th Jan 202610:18 amRNSHolding(s) in Company
28th Jan 202610:42 amRNSDirector/PDMR Shareholding
12th Jan 20264:38 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSChristmas Trading Results
2nd Jan 20269:00 amRNSTotal Voting Rights
2nd Jan 20269:00 amRNSBlock listing Interim Review
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
30th Dec 202512:40 pmRNSDirector/PDMR Shareholding
11th Dec 202510:00 amRNS2025 PSP Award Targets
10th Dec 202510:39 amRNSDirector/PDMR Shareholding
3rd Dec 20254:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20251:43 pmRNSDirector/PDMR Shareholding
1st Dec 20255:34 pmRNSDirector/PDMR Shareholding
1st Dec 20259:00 amRNSTotal Voting Rights
28th Nov 202512:55 pmRNSDirector/PDMR Shareholding
17th Nov 20259:00 amRNSDirectorate change
12th Nov 20255:11 pmRNSDirector/PDMR Shareholding
12th Nov 20259:00 amRNSDirectorate change
11th Nov 202512:00 pmRNSInvestor Presentation
5th Nov 20257:00 amRNSHalf-year Financial Report
3rd Nov 20259:00 amRNSTotal Voting Rights
30th Oct 202510:00 amRNSDirectorate Change
28th Oct 20254:56 pmRNSDirector/PDMR Shareholding
14th Oct 202510:00 amRNSMarks and Spencer Chairmanship
1st Oct 20259:00 amRNSTotal Voting Rights
30th Sep 202511:36 amRNSDirector/PDMR Shareholding
1st Sep 20259:00 amRNSTotal Voting Rights
28th Aug 20252:23 pmRNSDirector/PDMR Shareholding
20th Aug 20259:30 amRNSDirectorate Change
1st Aug 20259:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.